Results 171 to 180 of about 3,126,496 (202)
Some of the next articles are maybe not open access.
Management of Essential Thrombocythemia
Hematology, 2011Abstract Essential thrombocythemia (ET) is a Philadelphia chromosome (Ph)–negative myeloproliferative neoplasm (MPN) characterized by thrombocytosis and megakaryocytic hyperplasia of the bone marrow, with presence of the JAK2 V617F mutation in 50%-60% of patients. ET evolves to myelofibrosis in a minority of cases, whereas transformation
openaire +2 more sources
Pipobroman therapy of essential thrombocythemia
European Journal of Haematology, 1986We report our results with pipobroman (PB) therapy in patients with essential thrombocythemia (ET). 21 consecutive untreated patients were treated with PB from 1975 to 1984. PB was given at a dose of 1 mg/kg/d until platelet count dropped below 600 × 109/l. In 18 patients (86%) a hematological remission was obtained.
MAZZUCCONI, Maria Gabriella +6 more
openaire +3 more sources
The pathogenesis of essential thrombocythemia
Current Opinion in Hematology, 2011The identification of new mutations continues to further our understanding of the molecular pathogenesis of essential thrombocythemia and related disorders, and offers opportunities for improvements in diagnosis, risk stratification and disease classification.Molecular lesions in essential thrombocythemia affect two distinct pathways: cytokine ...
openaire +2 more sources
The Journal for Nurse Practitioners, 2023
Ruth Madden Foreman, Richard Brzustowicz
openaire +1 more source
Ruth Madden Foreman, Richard Brzustowicz
openaire +1 more source
Current Management Strategies for Polycythemia Vera and Essential Thrombocythemia
Blood Reviews, 2020Alessandro Maria Vannucchi +1 more
exaly
Hydroxyurea Compared With Anagrelide in High-Risk Essential Thrombocythemia
New England Journal of Medicine, 2005Anthony R Green +2 more
exaly
Hydroxyurea for Patients With Essential Thrombocythemia and a High Risk of Thrombosis
New England Journal of Medicine, 1995Marco Ruggeri +2 more
exaly
When and How to Treat Essential Thrombocythemia
New England Journal of Medicine, 2005Tiziano Barbui, Guido Finazzi
exaly

